Zhongguo Zhong Yao Za Zhi. 2020 Oct;45(19):4537-4544. doi: 10.19540/j.cnki.cjcmm.20200603.609.
With the application and popularization of PCR(polymerase chain reaction) technology in drug quality control, the ge-neral rule of PCR has been approved to be listed in the Chinese Pharmacopoeia(2020 edition). This rule has set general quality stan-dards for species identification in Chinese herbal medicine and biochemical medicine, as well as quality control of other medicines. The general rule is composed of general requirements for instruments, general requirements for PCR system, operational suitability test, measurement procedure(sample pretreatment, templates preparation, primers, nucleic acid amplification, reaction products detection, result judgment) and notes, etc. In this article, we introduced the general rule of PCR and its drafting instructions. Furthermore, its application perspective in Chinese herbal medicine and biochemical medicine was discussed.
随着聚合酶链反应(PCR)技术在药品质量控制中的应用与推广,PCR通则已被批准列入《中国药典》(2020年版)。该通则对中药材、生化药品及其他药品的品种鉴定和质量控制制定了通用的质量标准。通则由仪器的通用要求、PCR系统的通用要求、操作适用性试验、测定法(供试品预处理、模板制备、引物、核酸扩增、反应产物检测、结果判定)及注释等组成。本文介绍了PCR通则及其起草说明,并探讨了其在中药材和生化药品中的应用前景。